These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9575430

  • 1. Prognostic role of proliferating cell nuclear antigen in lung cancer: an immunohistochemical analysis.
    Caputi M, Esposito V, Groger AM, Pacilio C, Murabito M, Dekan G, Baldi F, Wolner E, Giordano A.
    In Vivo; 1998; 12(1):85-8. PubMed ID: 9575430
    [Abstract] [Full Text] [Related]

  • 2. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 3. Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen.
    Caputi M, Groeger AM, Esposito V, Dean C, De Luca A, Pacilio C, Muller MR, Giordano GG, Baldi F, Wolner E, Giordano A.
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):746-50. PubMed ID: 10101007
    [Abstract] [Full Text] [Related]

  • 4. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Apr; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 5. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K.
    Anticancer Res; 2005 Apr; 25(5):3437-43. PubMed ID: 16101161
    [Abstract] [Full Text] [Related]

  • 6. [Estrogen receptor in female lung carcinoma].
    Yang MH.
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Jun; 15(3):138-40, 189. PubMed ID: 1335368
    [Abstract] [Full Text] [Related]

  • 7. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K.
    Anticancer Res; 2001 Jun; 21(4A):2357-62. PubMed ID: 11724293
    [Abstract] [Full Text] [Related]

  • 8. [Study of the expression of proliferating cell nuclear antigen and p185 in non-small cell lung carcinoma].
    Alemany Monraval P, Martorell Cebollada M, Salvador Villalba I, Martínez Leandro E.
    Arch Bronconeumol; 1996 Apr; 32(4):165-9. PubMed ID: 8689012
    [Abstract] [Full Text] [Related]

  • 9. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
    Huh JW, Kim HR, Kim YJ.
    Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
    [Abstract] [Full Text] [Related]

  • 10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Jun; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 11. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A, Ueoka H, Yoshino T, Chikamori K, Onishi K, Kiura K, Bessho A, Mimoto J, Date H, Ando A, Shimizu N, Harada M.
    Oncol Rep; 1999 Jun; 6(1):75-80. PubMed ID: 9864405
    [Abstract] [Full Text] [Related]

  • 12. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
    Joseph MG, Banerjee D, Kocha W, Feld R, Stitt LW, Cherian MG.
    Cancer; 2001 Aug 15; 92(4):836-42. PubMed ID: 11550155
    [Abstract] [Full Text] [Related]

  • 13. Expression of p21 in non small cell lung cancer relationship with PCNA.
    Groeger AM, Caputi M, Esposito V, Baldi A, Rossiello R, Santini D, Mancini A, Kaiser HE, Baldi F.
    Anticancer Res; 2000 Aug 15; 20(5A):3301-5. PubMed ID: 11062757
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 15; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 15. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J, Xu YJ, Zhang ZX, DU CL, Qiao LF, Ni W, Chen SX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct 15; 30(10):771-5. PubMed ID: 18218209
    [Abstract] [Full Text] [Related]

  • 16. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
    Caputi M, Groeger AM, Esposito V, De Luca A, Masciullo V, Mancini A, Baldi F, Wolner E, Giordano A.
    Clin Cancer Res; 2002 Dec 15; 8(12):3850-6. PubMed ID: 12473599
    [Abstract] [Full Text] [Related]

  • 17. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
    Koshikawa T, Nakamura S, Kitoh K, Hayashi K, Suyama M, Kunishima K.
    Rinsho Byori; 1993 Jun 15; Suppl 94():113-24. PubMed ID: 8103122
    [No Abstract] [Full Text] [Related]

  • 18. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM, Kraegel SA, Madewell BR.
    J Comp Pathol; 1999 May 15; 120(4):321-32. PubMed ID: 10208729
    [Abstract] [Full Text] [Related]

  • 19. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY, Stephenson M, Gondo MM, Medeiros LJ, Cagle PT.
    Mod Pathol; 2000 Jul 15; 13(7):808-13. PubMed ID: 10912942
    [Abstract] [Full Text] [Related]

  • 20. [Clinical classification of central lung cancer in the light of late results of surgical treatment].
    Drukin EIa, Karaseva NA.
    Vestn Khir Im I I Grek; 1990 Jul 15; 145(7):117-20. PubMed ID: 2176369
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.